Suzuki cross-coupling polymerisation of aryldibromides and aryldiboronate esters in a sodium dodecyl sulfate (SDS)-stabilised miniemulsion provides a versatile and direct route to fluorescent conjugated polymer nanoparticles (CPNs). These nanoparticles have a conjugated backbone based on poly(9,9-dioctylfluorene) (PFO), however, significant structural diversity is introduced by incorporation of electron withdrawing, heterocyclic comonomers (5-50 mol.
Introduction
Conjugated polymer nanoparticles (CPNs), sometimes referred to as conjugated polymer dots, have been examined for a wide range of fluorescence-based cellular labelling and biomedical imaging applications. In vitro, CPNs display low cytotoxicity and can be internalized by cells through several active mechanisms that depend on the size and nature of the nanoparticle surface. [1] [2] [3] [4] Recent developments include the use of CPNs for in vivo targeted bioimaging of tumours, highlighting the potential of these materials as molecular imaging probes in a clinical setting. [5] [6] [7] [8] [9] CPNs do not show the undesirable fluorescence blinking behaviour and inherent toxicity associated with heavy-metal (e.g. Cd, Pb) derived quantum dots that are often used in similar applications. [10, 11] Two methods for the formation of CPNs have dominated literature reports to-date: i) nanoprecipitation, in which a dilute solution of a conjugated polymer (CP) in a water miscible, 'good solvent' (usually tetrahydrofuran) is added rapidly to a non-solvent (water), [12] [13] [14] and ii) miniemulsion, in which a solution of a CP in a non-water miscible, volatile solvent (e. g. dichloromethane) is emulsified in an aqueous solution of an appropriate surfactant, followed by solvent evaporation. [15] [16] [17] Both of these processing techniques are relatively straightforward and applicable to a range of commercially available CPs. The major limitation of these approaches is a lack of scalability: nanoprecipitation is particularly problematic in this respect in that it can only be achieved using very dilute polymer solutions and thus the resultant CPN dispersions have low solids contents (typically < 500 ppm). Miniemulsion of pre-formed CPs can be used to produce stable CPN dispersions at higher concentrations, but this approach necessitates the use of a multistep procedure in which the CP is initially prepared and isolated using conventional synthetic methods prior to subsequent dispersion in the miniemulsion.
In an effort to minimize these limitations, various research groups have developed synthetic routes to CPNs in which the polymerisation and nanoparticle formation are achieved concurrently. [7, [18] [19] [20] [21] [22] [23] [24] The various classes of light-emitting CPs from which formation of CPNs is desirable are structurally diverse and, moreover, their optical bandgap (and consequently their fluorescence emission wavelength) is directly controlled by the chemical composition of the polyaromatic backbone. Consequently, the scope of any direct synthetic route to CPNs is very much reliant on the versatility of the underlying polymerisation technique. Weder et al. pioneered this one-pot approach to CPNs, through their early report of the synthesis of hyperbranched poly(phenylene ethynylene) (PPE) nanoparticles via Sonogashira coupling of A 2 + B 2 + A 3 monomers (where A = bromo/iodo, B = ethynyl) in emulsified droplets of toluene in an aqueous solution of the ionic surfactant sodium dodecylsulfate (SDS). [18] Most notably, the authors demonstrated that use of an ultrasonic bath for emulsification enabled the synthesis of fluorescent nanoparticles with average diameters ranging from 400-500 nm. The scope for heterogeneous Sonogashira polymerisation reactions to be used in the direct synthesis of PPE-based CPNs has since been considerably extended by Mecking et al. [19] Here the authors focused on A 2 + B 2 stepgrowth reactions, employing the same catalytic system (Pd(PPh 3 ) 4 , CuI, diisopropylamine), dispersed solvent (toluene) and surfactant (SDS) as the earlier report. More rigorous sonication prior to polymerisation was found to enable the formation of smaller nanoparticles (average diameter = 60-120 nm), which were of an appropriate size for use in intracellular explored the use of a non-ionic surfactant (Tween 80) for the heterogeneous, Suzuki polymerisation reaction of either 2,7-dibromo-9,9-dioctylfluorene or 4,7-dibromo-2,1,3-benzothiadiazole with a slight excess of 9,9-dioctylfluorene-2,7-diboronic acid bis (1,3- propanediol) ester and a small amount of 1,3,5-tribromobenzene (2 mol. %). [21] These reactions provide blue or green fluorescent CPNs (average diameter = 100 -200 nm) comprised of CPs with a hyperbranched structure. We have recently demonstrated that when carried out at room temperature, Suzuki emulsion polymerisation reactions with Triton-X102 as surfactant produce either rod-like or spherical nanoparticles, depending on the chemical structure of the conjugated polymer. [24] The use of ionic surfactants in heterogeneous Suzuki polymerisation has advantages for emulsion stability where higher temperatures are required and also makes surfactant removal during purification steps less challenging. Ionic surfactants typically have higher critical micelle concentrations (CMCs) and lower micellar molecular weights (MMWs) than nonionic surfactants, rendering them readily amenable to removal by dialysis. Furthermore, ionic surfactants often have much higher cloud points than their non-ionic counterparts (usually > 100 °C). Mecking and co-workers have reported the direct synthesis of poly(9,9-dioctylfluorene) CPNs via the Suzuki polymerisation reaction of an A-B type monomer, 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7-bromo-9,9-dioctylfluorene, in an SDSstabilised miniemulsion using Pd(PPh 3 ) 4 as a catalyst and sodium hydroxide as base. [23] <Scheme 1 inserted her> Destabilisation of the miniemulsion was avoided by using the minimum amount of base (2 mol. equivalents) necessary to promote the catalytic reaction. A similar approach has since been employed for the synthesis of CPNs by reaction of 9,9-dioctylfluorene-2,7-diboronic acid bis(1,3-propane-diol) ester and 1,3,5-dibromobenzene in a miniemulsion that was stabilised by the cationic surfactant cetyl trimethylammonium bromide. [22] Both of these reports provide useful strategies for the direct synthesis of CPNs with relatively small diameters (ca. 40-150 nm), but are limited in their scope in that both reports focused on the preparation of fluorene homopolymers.
In order to demonstrate that Suzuki miniemulsion polymerisation reactions are robust, generally applicable and afford considerable structural diversity, we herein report the use of this technique for the polymerisation of a range of A 2 + B 2 type monomers. All reactions contain 50 mol. % of 2,2'-(9,9-dioctyl-9H-fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 2, as the B 2 monomer: structural variety is achieved through reaction with different A 2 comonomers to copolymers of poly(9,9-di-n-octylfluorenyl-2,7-diyl) (PFO). This approach provides access to either alternating co-polymers (with 50 mol. % of a single A 2 comonomer) or random copolymers (with varying molar ratios of two different A 2 comonomers). The latter approach gives valuable information on the optimal incorporation (mol. %) of comonomers to ensure a complete bathochromic shift in fluorescence emission in the resultant CPNs while minimising detrimental effects on quantum yield that were found to arise from increased interchain aggregation at higher levels of incorporation. The compatibility of these nanoparticles with standard cellular imaging and analysis techniques, such as microscopy and flow cytometry, has been assessed.
Experimental

Materials
2,7-Dibromo-9,9-dioctyl-9H-fluorene, 1, was synthesised from 2,7-dibromofluorene (97%, Sigma Aldrich) using standard literature procedures. [25, 26] 2,2'-(9,9-Dioctyl-9H-fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 2, was prepared from 1, again using a standard literature procedure. [27] 4,7-Dibromo-2,1,3-benzothiadiazole, 3, was prepared in two steps from o-phenylenediamine (>99%, Sigma Aldrich) by modification of a literature method. [28] The method employed was identical save that in the first step direct extraction into dichloromethane of the intermediate, 2, 1, 3-benzothiadiazole, from acid solution was employed rather than steam distillation, and the isolated compound was then directly brominated to give 3. The spectroscopic data for each compound was in agreement with that reported in the literature. Amberlite XAD-2 resin, tetrakis(triphenylphosphine)palladium (0) and monomer 4 were purchased from Sigma Aldrich. All commercially sourced compounds were used as received, without further purification.
Miniemulsion Polymerisation
The following procedure for the synthesis of NP1a is representative of the method used to synthesise all of the CPN samples discussed. Sodium dodecyl sulfate (50.0 mg) and deionized water (20 mL) were transferred to a Schlenk tube and the resultant solution was degassed by bubbling with argon for 20 minutes. Monomers 1 (50.0 mg, 9.12 x 10 -2 mmol) and 2 (58.6 mg, 9.12 x 10 -2 mmol) were dissolved in toluene (1.00 mL), to which hexadecane (78 µL) was also added, and this solution was degassed for 5 minutes in the same manner. Tetrakis(triphenylphosphine)palladium(0) (2.2 mg, 1.90 x 10 -3 mmol) was added to the monomer solution, which was then transferred to the reaction vessel. The reaction mixture was emulsified by ultrasonication (Cole Parmer 750W ultrasonicator, fitted with microtip, set to 22 % power) for 2 minutes while cooling with an ice bath. The Schlenk tube was resealed and the miniemulsion was heated to 72 °C, followed by addition of 1M aqueous sodium hydroxide solution (365 µL), and the reaction mixture was stirred for 16 hours. After cooling to room temperature, the cap of the reaction vessel was removed and the emulsion was stirred for 5 hours to remove the residual toluene. The effective conjugated polymer concentration generated in this particular miniemulsion is approx. 3500 ppm, higher than that typical achievable via nanoprecipitation.
Note: For NP1b, the amount of water used in the reaction was halved (10 mL) compared to the amount used for synthesis of NP1a. This equates to an effective conjugated polymer concentration in the resultant miniemulsion of approx. 7000 ppm. For NP2a-c and NP3a-b the only change to the procedure described for NP1a is the choice of comonomers and the molar ratio of these monomers (Table 1) . In each reaction, the total number of moles of the combined comonomers was 1.82 x 10 -1 mmol.
Surfactant Removal
To prepare the nanoparticle dispersions for use in cellular assays, a 4 mL aliquot of the asprepared dispersion was added to 200 mg of Amberlite XAD-2 resin (prewashed twice with deionised water) and this suspension was shaken at room temperature for one hour. The resin was removed by decantation of the aqueous nanoparticle dispersion (using a syringe with a fine needle) and a fresh batch of resin (200 mg) was subsequently added. After shaking for a further hour, the nanoparticle dispersion was similarly decanted and then filtered through glass wool to remove any residual beads of the Amberlite XAD-2.
2.4. Characterisation 2.4.1. DLS Analysis DLS particle size analysis of the nanoparticles in water was carried out after dilution of the as-prepared aqueous nanoparticle dispersion (400 µL) with deionised water (1.6 mL) and surfactant removal (as described above, using 2 x 20 mg of Amberlite XAD-2), using a Malvern Zetasizer Nano ZS. All DLS particle size analyses were carried out at a controlled temperature of 20 °C.
GPC Analysis
In order to prepare THF solutions of the linear CPs that comprise NP1a-b, NP2a-c and NP3a-b, a 200 μL aliquot of the as-prepared nanoparticle dispersion was flocculated through addition of 1.3 mL methanol and the polymer was isolated by centrifugation (14,000 rpm, 1 minute) and decantation of the supernatant. The polymer was dried in air to remove residual methanol before dissolving in tetrahydrofuran (1 mL) and the resultant solution was filtered through a 0.45 μm syringe filter. GPC analysis was carried out at 35 °C using a Viscotek
GPCmax VE2001 solvent/sample module with 2 × PL gel 10 μm Mixed-B and PL gel 500A
columns, a Viscotek VE3580 RI detector and a VE 3240 UV/VIS 50 multichannel detector.
The flow rate was 1 mL/min and the system was calibrated with low polydispersity polystyrene standards in the range of 200 to 180 ×10 4 g mol -1 from Agilent. The analysed samples contained n-dodecane as a flow marker.
UV/Vis and PL Analysis
For recording of absorption and emission spectra in water, the aqueous nanoparticle dispersion (as-prepared for DLS analysis, described above) was diluted with water to an optical density of between 0.5 and 1. UV-Vis absorption spectra of the nanoparticles at this concentration were recorded on a Varian Cary 55 5000UV-Vis-NIR spectrophotometer at room temperature. PL spectra were recorded on a Varian Cary Eclipse fluorimeter.
<Table 1 inserted here>
PLQY Analysis
All PLQY measurements were obtained using a Fluoromax-4 spectrofluorometer with integrating sphere attachment (instrument standardized with a Tungsten lamp). Nanoparticle suspensions in water were diluted to an optical density < 0.2 for measurements. Background reference measurements were obtained using water (600 µL) in 7 x 40 mm clear glass vials.
Nanoparticle suspensions (600 µL) were also measured in 7 x 40 mm clear glass vials. An excitation wavelength of 390 nm was used for all samples apart from F8BT nanoparticles Figure 1 ). There is some disparity in size between the distributions obtained via DLS and TEM for all samples (see Table 1 ), due to the relatively polydisperse nature of the samples. However, both methods are in agreement that the majority of particles present in all samples are below 100 nm in diameter and thus readily amendable to entry into cells by active mechanisms, e.g. endocytosis. [30] Moreover, CPNs prepared by precipitation with a similar level of polydispersity within this size regimen have been successfully employed in real-time sentinel lymph node mapping in vivo. [7] Purification of the CPNs for application in cellular imaging requires removal of the organic solvent (toluene) and free surfactant. Removing the lid of the reaction vessel and stirring at room temperature for 5 hours achieved the former, while the latter can be achieved by an exhaustive dialysis of the dispersion (7 days, changing the water twice daily). However, dialysis is both time-consuming, causing a considerable bottleneck in CPN production, and expensive, hence an alternative strategy was investigated. In protein purification detergent removal (ionic and non-ionic surfactants) can be achieved by the use of a porous, hydrophobic polystyrene resin, Amberlite XAD-2. [31, 32] It was found that for the CPNs prepared in this work it was possible to remove both the residual toluene and the SDS to a final level that is below the surfactant CMC by simply shaking the crude nanoparticle suspension (as a 5-fold dilution) with 1 wt. % of Amberlite XAD-2 for 15 minutes and then repeating this process with a fresh batch of resin. Analysis of the samples purified by this method by DLS shows no detrimental effects on the CPN size or polydispersity (Table 1) .
Unlike dialysis, purification using the resin does not remove the aqueous base (sodium hydroxide) employed in the polymerisation, however it was at a sufficiently low level that the as-purified CPN suspension could be added directly to biological buffer solutions without the need for further purification. Using this approach it is possible to produce sub-100 nm PFO nanoparticles at high concentrations (NP1b , Table 1 ), [23] indicating that A 2 + B 2 reactions can provide an acceptably high degree of polymerisation while providing the possibility of vastly expanding the structural diversity.
Green-Emitting CPNs
The emission wavelength of fluorene polymers can be tuned through copolymerisation of fluorene with various electron withdrawing co-monomers. [36, 37] Miniemulsion copolymerisation of dioctyl fluorene monomers 1 and 2 with benzothiadiazole monomer 3 gave CPN dispersions, NP2a-c, that luminesce primarily in the green (Table 2 ). NP2a and NP2b are comprised of random copolymers, synthesised by reaction of 1 and 2 with 5 and 10 mol.
% of 3, respectively. The UV/vis absorption spectra of NP2 are similar to those of NP1 (Figure 3 ) due to the relative abundance of fluorene-fluorene segments in these materials.
The secondary absorption peak observed at 437 nm for NP2 shows that the polymers in these nanoparticles retain the ability to form the more ordered β-phase conformation, despite the incorporation of small amounts of the benzothiadiazole units. [38] The absorbance of the fluorene-benzothiadiazole segments in NP2 is observed as a broad shoulder that partially overlaps with the β-phase absorption and that extends to around 500 nm (Figure 3a) . The PL emission of these copolymers (exciting at 390 nm) is almost exclusively derived from the relatively few fluorene-benzothiadiazole chain segments, as a result of efficient Förster
Resonance Energy Transfer (FRET) between these and the fluorene-fluorene segments ( Figure 3b) . As a result, the effective Stokes shift for both samples is large (154 nm).
Increasing the amount of benzothiadiazole monomer 3 from 5 to 10 mol. % resulted in a significant increase in the PLQY (Table 2) of the resultant nanoparticles, NP2a and NP2b, with the value for the latter (56 %) being much higher than those typically reported for green emitting CPNs. resulted in a reduction in the molecular weight of the polymer (5.7 x 10 3 g mol -1 ) contained within these nanoparticles, when compared with those produced in the other miniemulsion reactions (see Table 1 ). GPC analysis of the polymer from NP3a indicated a number average molecular weight of 1. Factors that may contribute to the lower efficiency of NP3b when compared to NP3a are the lower molecular weight of the CP chains in NP3b and the increased interchain aggregation caused by the higher mol. % of red-emitting segments. This is evidenced by the reduced amount of PFO β-phase observed in the UV/vis spectrum of NP3b (Figure 5b ). demonstrating that it is a good candidate for use in microscopy studies. The cytotoxicity of nanoparticles NP1a, NP2c and NP3a was tested using the Alamar Blue assay. After incubation for 24 hours the particles reduced viability by a maximum of 25 % of untreated controls (Table 3) . At higher concentrations the viability dropped further (Figure 8 ) however such high concentrations were well beyond those necessary for bioimaging purposes. 
Conclusions
We have demonstrated the wider utility of Suzuki emulsion polymerisation for the direct synthesis of CPNs with tunable fluorescence emission. Their useful optical properties, such as high PLQYs, and small size (< 100 nm) render these nanoparticles suitable for use in biological applications, such as cellular imaging and sorting via fluorescence microscopy and flow cytometry. The methodology developed is straightforward in terms of both synthesis and purification and more readily scalable than many previously reported methods for producing CPNs. Through developing a deeper understanding of the mechanism of Suzuki emulsion polymerisation reactions and, in particular, the factors that control particle size, and use of biocompatible surfactants, one pot synthesis of CPNs has the potential to supersede current indirect methodologies (e. g. nanoprecipitation) and to support the wider use of these materials in biomedical imaging.
Figure Captions
Scheme 1. Selection of monomers employed in miniemulsion polymerisation reactions and resultant copolymers from which CPNs are comprised. Table 1 . Composition, particle size and copolymer molecular weight of CPNs synthesized via Suzuki polymerisation in a miniemulsion. Plasma membrane prior to fixing (NP2c) and visualisation by confocal microscopy (Scale bar = 10 µm). NP1a: particles-blue; NP2c: nucleus-blue, particles-green, plasma membrane-red;
NP3a: particles-red. incubated with particles at the stated concentrations for 24 hours after which time the cell viability was measured using Alamar blue assay. N=4, error bar SD. Table 3 . Mean cell viability after 24 hour incubation with 50 µg/ml of particles. Tables   Table 1   Sample )
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